GSMs offer new link between Alzheimer's and heart disease

By | June 13, 2008, 9:28am PDT

Summary: What makes GSMs so promising is that, while statins may stop plaque from forming they do nothing about plaque which is there, while with the new drugs “GSM agents actually stick to the Abeta already in the brain, keeping it from aggregating.”

Gamma Secretase Modulator from CIPSA newly-patented class of drugs called gamma-secretase modulators (GSMs) is not only offering new hope for Alzheimer’s patients, but a clearer link between that and heart disease.

(Picture of a GSM from CIPS.)

The reason, as the Mayo Clinic notes, lies in how they work, by reducing production of long pieces of the amyloid beta protein (Abeta) that form clumps, while increasing production of shorter strings of the same protein that can keep the longer strings from sticking together.

Think of how rice cooks. Short grain rices stick together in a risotto. Long grain rises remain separate in a pilaf. The reason is the mix of proteins in the different rice grains.

In this case you’re talking about different versions of the same protein but it’s the same effect. Better your blood is a pilaf than a risotto.

In controlling this process you control the creation of plaque, which clogs the brain arteries of Alzheimers’ patients, killing them slowly. But plaque is also the cause of heart attacks, clogging arteries feeding the heart muscle, killing folks quickly.

What makes GSMs so promising is that, while statins may stop plaque from forming they do nothing about plaque which is there, while with the new drugs “GSM agents actually stick to the Abeta already in the brain, keeping it from aggregating.”

Senior study author Tony Golde was quite explicit in the link between the diseases:

“In a very general sense the action of these GSM on Abeta might be analogous to some cholesterol lowering drugs that can lower LDL, the bad cholesterol that sticks to your arteries, and can raise HDL, the good cholesterol that sweeps out LDL.”

Five months ago, in the Fight over Statins, I casually mentioned studies of statins and Alzheimers, some of them contradictory, suggesting the problem in both cases is the same as with Atlanta traffic, clogged arteries.

A personal note here. My father died of heart disease, my grandfather of Alzheimer’s. The idea of them having similar risk factors and causes is not foreign to me.

All this is a long way from making it to your loved one’s bedside. But perhaps we can get it to yours and mine.

Kick off your day with ZDNet's daily e-mail newsletter. It's the freshest tech news and opinion, served hot. Get it.

Topics

Disclosure

Dana Blankenhorn

Dana Blankenhorn has been a journalist, writer and part-time futurist for over 30 years. At the present moment I run only a personal blog in addition to my ZDNet open source blog. DanaBlankenhorn.Com has the subtitle The War Against Oil. In the past I have used it to write about political history, e-commerce, personal matters, some ideas related to open source, and The World of Always On, which is the idea of using sensors, motes and RFID to turn WiFi links into platforms for applications which live in the air. My IRA account at Schwab holds a few tech shares, most notably some Intel and Applied Materials, but there are no open source companies in it. I don’t even own any CBS stock.

Biography

Dana Blankenhorn

Dana Blankenhorn has been a business journalist since 1978, and has covered technology since 1982. He launched the Interactive Age Daily, the first daily coverage of the Internet to launch with a magazine, in September 1994.
2
Comments

Join the conversation!

Just In

I quoted directly from the Mayo Clinic story...
DanaBlankenhorn 14th Jun 2008
So am I wrong or are they? I'm confused here.

The point of the Mayo Clinic is they're not so different as we have assumed, and may respond to similar treatments, based on similar biochemical understandings.
0 Votes
+ -
You've got it wrong!
obrie004 14th Jun 2008
The "plaque" that forms in Alzheimer's disease brains is biochemically and pathologically completely different than the "plaques" that form in arteries with atherosclerosis. The link between these two conditions and treatment thereof that is implied in this article is non-existent. The author should get the facts straight before posting such an article.
0 Votes
+ -
I quoted directly from the Mayo Clinic story...
DanaBlankenhorn 14th Jun 2008
So am I wrong or are they? I'm confused here.

The point of the Mayo Clinic is they're not so different as we have assumed, and may respond to similar treatments, based on similar biochemical understandings.

Join the conversation!

Formatting +
BB Codes - Note: HTML is not supported in forums
  • [b] Bold [/b]
  • [i] Italic [/i]
  • [u] Underline [/u]
  • [s] Strikethrough [/s]
  • [q] "Quote" [/q]
  • [ol][*] 1. Ordered List [/ol]
  • [ul][*] · Unordered List [/ul]
  • [pre] Preformat [/pre]
  • [quote] "Blockquote" [/quote]
ie8 fix

The best of ZDNet, delivered

ZDNet Newsletters

Get the best of ZDNet delivered straight to your inbox

Facebook Activity

White Papers, Webcasts, & Resources
ie8 fix
ie8 fix